Skip to content
Last session
PDI $14.38 ▲2.86%D 3.0%DXYZ $28.88 ▼3.86%D 15.8%GOF $8.60 ▲1.44%D 13.7%VCX $25.44 ▲0.24%D 33.3%NEA $10.04 ▲2.53%D 1.8%PTY $10.82 ▲2.08%D 0.6%CLM $6.27 ▼0.61%D 1.4%NAD $10.32 ▲2.59%D 2.4%BCAT $13.14 ▼0.83%D 11.8%PDO $11.94 ▲1.88%D 2.2%JPC $6.80 ▲2.06%D 8.1%UTG $35.05 ▼1.04%D 5.0%BPRE $12.49 ▼0.48%D 46.9%NVG $10.83 ▲2.55%D 2.1%NZF $10.97 ▲2.88%D 1.4%BOT $26.18 ▼3.71%P 256.7%NMZ $9.11 ▲2.65%D 0.7%NAC $10.10 ▲2.74%D 2.1%CRF $5.93 ▼0.38%D 3.9%OXLC $8.36 ▲1.70%MQY $10.20 ▲3.01%D 7.2%RQI $11.15 ▲1.55%D 9.1%UTF $25.53 ▲0.04%D 3.3%ECAT $13.57 ▲0.63%HYT $7.74 ▲1.15%D 11.5%DNP $9.83 ▼0.25%P 6.4%NUV $8.23 ▲1.51%D 4.0%USA $5.98 ▲1.87%D 11.8%ADX $25.79 ▲0.55%D 4.1%DSL $9.78 ▲1.45%D 10.9%MHD $10.34 ▲2.47%D 9.3%TYG $38.43 ▼1.31%D 12.5%MUC $9.70 ▲1.29%D 8.6%MYI $9.78 ▲3.33%D 7.4%ASGI $19.33 ▲0.78%D 8.9%PHK $4.08 ▲1.49%D 4.2%JFR $7.32 ▲1.36%D 10.5%BSTZ $27.95 ▼0.56%EVV $8.35 ▲1.46%D 13.0%PCN $10.70 ▲1.90%D 1.8%

Which closed-end funds own Biomarin Pharmaceutical Inc?

11 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $11.2M. Security type: loan. Country: United States. CUSIP 09075UAD6 · ISIN US09075UAD63.

Holdings are historical filings (report dates May 31, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.

Funds holding this security

FundCategoryWeightValue (USD)BalanceFund net assetsPrem/discReport date
JQC Nuveen Credit Strategies Income FundTaxable Bonds0.22%$2.6M2,567,714 par$1.2B12.8% discountJul 31, 2026
JFR Nuveen Floating Rate Income FundSenior Loans0.21%$4.6M4,609,750 par$2.2B10.5% discountJul 31, 2026
BGT BlackRock Floating Rate Income TrustSenior Loans0.14%$593K593,000 par$421M7.1% discountJun 30, 2026
FRA BlackRock Floating Rate Income Strategies FundSenior Loans0.14%$722K722,000 par$515M8.6% discountJun 30, 2026
DSU BlackRock Debt Strategies FundTaxable Bonds0.11%$838K838,000 par$750M6.5% discountJun 30, 2026
BLW BlackRock Ltd Duration Income TrustTaxable Bonds0.11%$583K583,000 par$532M8.5% discountJun 30, 2026
VVR Invesco Senior Income TrustSenior Loans0.09%$721K719,377 par$787M13.3% discountMay 31, 2026
PPT Franklin Premier Income TrustTaxable Bonds0.05%$182K182,457 par$390M9.0% discountJul 31, 2026
PIM Franklin Master Intermediate Income TrustInvestment Grade0.04%$85K84,937 par$199M8.0% discountJun 30, 2026
NMAI Nuveen Multi-Asset Income FundMulti-Asset0.02%$152K152,000 par$691MNAV unavailableJun 30, 2026
BTZ BlackRock Credit Allocation Income TrustTaxable Bonds0.01%$103K103,000 par$1.2B9.7% discountJun 30, 2026

11 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.

Also listed in filings as: BioMarin Pharmaceutical; BioMarin Pharmaceutical Inc; BioMarin Pharmaceutical Inc..

Related securities from the same issuer

SecurityTypeFunds holding
Biomarin Pharmaceuticaldebt security17
Biomarin Pharmaceutical Inccommon equity7

Issuer-level search for “BIOMARIN PHARMACEUTICAL INC” → · Compare two funds’ portfolios →